NR1H4 and Hepatic fibrosis: They showed that LGG administration can prevent liver fibrosis by inhibiting liver bile acid synthesis through Farnesoid X receptor; fibroblast growth factor (FXR-FGF-15) mediated signaling in the intestinal tract in animal models [92].